| 产品编号 | bs-21190R |
| 英文名称 | SLC12A8 |
| 中文名称 | 溶质载体家族12成员8抗体 |
| 别 名 | Cation-chloride cotransporter 9; CCC9; DKFZp686L18248; FLJ23188; OTTHUMP00000215536; OTTHUMP00000215625; S12A8_HUMAN; Slc12a8; Solute carrier family 12 (potassium/chloride transporters), member 8; Solute carrier family 12 member 8. |
| 研究领域 | 细胞生物 信号转导 细胞膜蛋白 |
| 抗体来源 | Rabbit |
| 克隆类型 | Polyclonal |
| 交叉反应 | Human |
| 产品应用 | WB=1:500-2000, ELISA=1:5000-10000
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理论分子量 | 78kDa |
| 细胞定位 | 细胞膜 |
| 性 状 | Liquid |
| 浓 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human SLC12A8: 501-600/714 |
| 亚 型 | IgG |
| 纯化方法 | affinity purified by Protein A |
| 缓 冲 液 | Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4 |
| 保存条件 | Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 产品介绍 |
This gene is thought to be a candidate for psoriasis susceptibility. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Sep 2010] Function: Cation/chloride cotransporter that may play a role in the control of keratinocyte proliferation. Subcellular Location: Membrane. Tissue Specificity: Ubiquitous with very low level in normal skin. DISEASE: Note=SLC12A8 has been identified as a possible susceptibility gene for psoriasis mapped to chromosome 3q21 (PSORS5). Similarity: Belongs to the SLC12A transporter family. SWISS: A0AV02 Gene ID: 84561 Database links: Entrez Gene: 84561 Human Omim: 611316 Human SwissProt: A0AV02 Human Unigene: 658514 Human |
| 1、抗体溶解方法 | |
| 2、抗体修复方式 | |
| 3、常用试剂的配制 | |
| 4、免疫组化操作步骤 | |
| 5、免疫组化问题解答 | |
| 6、Western Blotting 操作步骤 | |
| 7、Western Blotting 问题解答 | |
| 8、关于肽链的设计 | |
| 9、多肽的溶解与保存 | |
| 10、酶标抗体效价测定程序 | |
